BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is usually a hypervascular
tumor. Factor VIII-related antigens, including von Willebrand factor, are k
nown to be expressed in HCC, which cause capillarization of the sinusoids o
f HCC. Capillarization of hepatic sinusoids may play a role in hepatocarcin
ogenesis and its metastasis. The aim of this study is to clarify the expres
sion of Factor VIII in patients with hepatitis B or C (n=18) and HCC (n=16)
,
METHODOLOGY: All specimens were sufficient for immunohistochemical study of
the neo-angiogenesis with regard to clinical results. Microvessel count pe
r square millimeter (MVC) and hot spot of microvessel per square millimeter
(HSV)were measured from the histochemical study.
RESULTS: In the patients with hepatitis group, the positive staining on the
vessels of the portal triad was 11.1% (2/18) but in the non-neoplastic tis
sue of HCC patients the positive rate was 68.7% (11/16) showing a significa
nt difference from the hepatitis group. The amount of vasculatures was easi
ly found in the surrounding capsule of resected HCC. The MVC of the capsule
was 10.17+/-2.78 and 13.66+/-5.42 for the HCC with non-direct invasion and
direct invasion during operation, respectively. The HSV of capsules were 7
.51+/-2.09 and 9.14+/-4.02 for the non-invasion and invasion, respectively.
Therefore, in our study, it is clear that the high MVC or HSV scores were
found in patients of direct invasion. However, there was no relation betwee
n hepatitis B or hepatitis C to the tumor invasiveness. The median survival
times were 21.5 months for the non-invasive group and 14.5 months for the
invasive group (p<0.05). The positive rate of Factor VIII in the vessels of
the portal triad were 60% and 83.3% for the non-invasive and invasive grou
ps, respectively. However, the lower values of MVC and HSV showed a trend t
oward a longer recurrence time.
CONCLUSIONS: It is pertinent to prove that the high score of neo-angiogenes
is has a high risk of recurrence. In addition, it is wise to pay more atten
tion to the interval of the follow-up study to detect the recurrent lesion
earlier, where possible, in the patient with a high score of microvasculari
ty.